ERCC4 and cancer: Substantial heterogeneities were observed among studies for the association between the XPF-rs1800067 polymorphism and cancer risk (homozygous model: χ2 = 31.02, df = 17, P = 0.020; recessive model: χ2 = 30.66, df = 17, P = 0.022).